Back
ESC Professional Premium Access

Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation

Session: Costs and cost-effectiveness
Topic: Public Health
Speaker: Doctor T. Beaulieu (Manhattan, US)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tara Beaulieu

Johnson & Johnson, Manhattan (United States of America)
0 follower

6 more presentations in this session

Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome

Speaker: Mr W. van den Broek (Nieuwegein, NL)

Access
Abstract
Slides
Like
Thumbnail

Dutch Nationwide Implementation Program for familial hypercholesterolemia case finding in children: a cost-effectiveness and return on investment analysis

Speaker: Associate Professor Z. Ademi (Melbourne, AU)

Access
Abstract
Slides
Like
Thumbnail

Cost-effectiveness of statin therapy in categories of patients in the UK

Speaker: Associate Professor B. Mihaylova (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK

Speaker: Mr D. Michaeli (Mannheim, DE) Mr T. Michaeli (Mannheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Counting the cost of progressive aortic valve stenosis: an international observational clinical cohort study

Speaker: Professor S. Stewart (Sydney, AU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Costs and cost-effectiveness

Speakers: Doctor T. Beaulieu, Mr W. van den Broek, Associate Professor Z. Ademi, Associate Professor B. Mihaylova, Mr D. Michaeli...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources